Skip to main content

Latest SEC Filings — Page 108

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

BioNTech to Present First Global Data for Pumitamig/Elfetabart Drozuntecan Combination at WCLC 2026
Form 6-KBNTX · Form 6-K · 2026-08-20
CEO Jason Hollar Sells $29.4M in Cardinal Health Shares
Form 4CAH · Form 4 · 2026-08-20
Jack in the Box Names Taylor Montgomery President, Sets CEO Succession Path
Form 8-KJACK · Form 8-K · 2026-08-20
Evaxion Q2 Loss Narrows, ATM Sale Adds $1.5M, Cash Runway to H2 2027
Form 6-KEVAX · Form 6-K · 2026-08-20
Wellchange Proposes 1-for-5 Class A Share Consolidation to Regain Nasdaq Compliance
Form 6-KWCT · Form 6-K · 2026-08-20
Apeiron Group Buys $2.9M of ENHA Stock on Open Market, Closes Second PIPE Tranche
ProForm 4ENHA · Form 4 · 2026-08-20
Autohome Q2 Revenue Falls 32% as Online Marketplace Slumps; Buyback Accelerates
ProForm 6-KATHM · Form 6-K · 2026-08-20
Yunji's Revenue Drops 39% in First Half 2026, but Cost Cuts Narrow Net Loss
Form 6-KYJ · Form 6-K · 2026-08-20
Electra Locks In 100% of Cobalt Feedstock Through 2027 with Glencore Extension
ProForm 6-KELBM · Form 6-K · 2026-08-20
Solmate's SOL Treasury Surpasses $100M After Additional 1,000 SOL Purchase
Form 6-KSLMT · Form 6-K · 2026-08-20
AIR Global Swings to $81.8M H1 Loss on $95.9M Listing Costs; Adjusted EBITDA Flat at $71.7M
ProForm 424B3AIIR · Form 424B3 · 2026-08-20
UroGen Pharma Secures Option to License IntraGel's SRGel Platform for Head and Neck Cancer
Form 8-KURGN · Form 8-K · 2026-08-20
AIR Global's H1 2026: Revenue Climbs 3.7% to $206.9M, Net Loss of $81.8M Tied to IPO Costs; FY26 Revenue Growth Guided at 4-6%
ProForm 6-KAIIR · Form 6-K · 2026-08-20
NovaBridge Reports H1 2026 Loss of $37.9M, Cash Runway Through 2028
Form 6-KNBP · Form 6-K · 2026-08-20
Investor Deck Highlights $216M Cash, Givastomig Phase 3 Timeline, and VIS-101 Phase 2b Start
Form 6-KNBP · Form 6-K · 2026-08-20
Aurora Mobile Q2 2026: Revenue Up 13%, Fifth Straight Profitable Quarter
Form 6-KJG · Form 6-K · 2026-08-20
AC Immune Reports Positive Phase 1 Data for NLRP3 Inhibitor ACI-19764
ProForm 6-KACIU · Form 6-K · 2026-08-20
iBio Seeks Shareholder Approval to Double Authorized Shares to 500M
Form PRE 14AIBIO · Form PRE 14A · 2026-08-20
Walmart Q2 FY27: Revenue Up 5.9%, Adjusted EPS $0.81, FY27 Guidance Raised
Form 8-KWMT · Form 8-K · 2026-08-20
Natuzzi Signs Definitive CEO Agreement; Shareholder Vote Set for Sept 11
Form 6-KNTZ · Form 6-K · 2026-08-20
Youdao Q2 2026: Operating Profit Nearly Triples, Eighth Straight Profitable Quarter
Form 6-KDAO · Form 6-K · 2026-08-20
DouYu Q2 2026: Revenue Misses, Swings to Net Loss on Investment Write-Down
Form 6-KDOYU · Form 6-K · 2026-08-20
Advance Auto Parts Q2 2026: Margin Expansion and Raised EPS Guidance
Form 8-KAAP · Form 8-K · 2026-08-20
BingEx Q2 Loss Reverses Year-Ago Profit; Buyback Reaches $11.8M
Form 6-KFLX · Form 6-K · 2026-08-20
Sunlands Q2 Revenue Falls 25%, Guides Q3 Down 33-37%
Form 6-KSTG · Form 6-K · 2026-08-20
NetEase Q2 Net Income Falls 18.8% on Investment Losses; Buyback and Dividend Continue
ProForm 6-KNTES · Form 6-K · 2026-08-20
BOXABL Delays 10-Q Filing Over Complex Prepaid Forward Accounting
Form 8-KFGMC · Form 8-K · 2026-08-20
Atour Q2 2026: Revenue Up 41%, Retail Surges 63%, Full-Year Growth Guided at 30%
Form 6-KATAT · Form 6-K · 2026-08-20
Odysight.ai Prices $11M Public Offering at $3.20/Share, Insiders Participate
Form 8-KODYS · Form 8-K · 2026-08-20
Livento Group Posts Q2 Loss, Cash Dwindles to $22K, and Adds Toxic Convertible Debt
ProForm 10-QLIVG · Form 10-Q · 2026-08-20